title: Effect of CD40 ligand on the course of murine histoplasmosis.
abstract: CD40 ligand-CD40 ligation is important in the development of T-cell-mediated immune responses. The purpose of this study was to examine the role of CD40L in recovery from histoplasmosis using a murine model of intratracheally induced infection. B6C3F1 mice were infected intratracheally with Histoplasma capsulatum yeast and monitored for clearance of the organism from the lungs and spleen. CD40L treatment was begun on either day -2 or +2 post inoculation and continued until day 14 in CD4-depleted animals and from day -2 to day +4 in non-immunosuppressed animals. Amphotericin B treatment was begun four days following inoculation and given every other day for 10 days. CD40L reduced fungal burden by less than one log when started two days before infection but did not act synergistically with low-dosage amphotericin B (0.2 mg kg(-1) qod) in CD4 depleted mice. Low-dose amphotericin B, CD40L, and the combination of the two failed to lower the fungal burden in a second experiment using a more virulent isolate of the same strain of H. capsulatum in CD4-depleted mice. Furthermore, CD40L did not increase the concentrations of IFN-gamma, IL-12 or IL-10 in the lungs or spleens of infected animals. In summary, CD40L had minimal or no effect on the course of infection in this murine model of histoplasmosis.
authors.affiliation: Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. jwheat@miravista.com
authors.forename: L J
authors.initials: LJ
authors.lastname: Wheat
authors.forename: M
authors.initials: M
authors.lastname: Durkin
authors.forename: C
authors.initials: C
authors.lastname: Schnizlein-Bick
authors.forename: E
authors.initials: E
authors.lastname: Bassey
authors.forename: S
authors.initials: S
authors.lastname: Kohler
authors.forename: P
authors.initials: P
authors.lastname: Connolly
authors.forename: J
authors.initials: J
authors.lastname: Goldberg
authors.forename: T
authors.initials: T
authors.lastname: Garringer
authors.forename: E
authors.initials: E
authors.lastname: Brizendine
authors.forename: E K
authors.initials: EK
authors.lastname: Thomas
mesh_terms: D000818:Animals; D015704:CD4 Antigens / Q000502:physiology; D023201:CD40 Ligand / Q000502:physiology / Q000627:therapeutic use*; D006660:Histoplasmosis / Q000188:drug therapy* / Q000276:immunology; D007371:Interferon-gamma; D016753:Interleukin-10 / Q000032:analysis; D018664:Interleukin-12 / Q000032:analysis; D008168:Lung / Q000276:immunology; D051379:Mice
chemical_list: D015704:CD4 Antigens; D016753:Interleukin-10; D023201:CD40 Ligand; D018664:Interleukin-12; D007371:Interferon-gamma